Nádia Emi Aikawa

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Ana Cristina de Medeiros Ribeiro, Nádia Emi Aikawa, Carla Gonçalves Schahin Saad et al. · Nature Medicine · 2021 · 214 citations

Vaccination, Rheumatology, Vaccine Safety +10

Vitamin D Supplementation in Adolescents and Young Adults With Juvenile Systemic Lupus Erythematosus for Improvement in Disease Activity and Fatigue Scores: A Randomized, Double‐Blind, Placebo‐Controlled Trial

Glauce Leão Lima, Juliane Aline Paupitz, Nádia Emi Aikawa et al. · Arthritis Care & Research · 2015 · 155 citations

Epidemiological and outcome characteristics of major burns in Tokyo

K. Kobayashi, Hiroto Ikeda, Ryouhei Higuchi et al. · Burns · 2004 · 142 citations

Epidemiology, Fire Safety, Environmental Health +9

Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases

Carla Gonçalves Schahin Saad, Eduardo Ferreira Borba, Nádia Emi Aikawa et al. · Annals of the Rheumatic Diseases · 2011 · 103 citations

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice

Ana Cristina de Medeiros Ribeiro, Lissiane Karine Noronha Guedes, Júlio César Bertacini de Moraes et al. · Annals of the Rheumatic Diseases · 2011 · 96 citations